| |
|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA9910811556303321 |
|
|
Titolo |
Scientific and policy considerations in developing smallpox vaccination options : a workshop summary / / Board on Health Promotion and Disease Prevention, Institute of Medicine of the National Academies |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Washington, D.C., : National Academy Press, c2002 |
|
|
|
|
|
|
|
ISBN |
|
0-309-16898-8 |
1-280-18311-X |
9786610183111 |
0-309-56635-5 |
|
|
|
|
|
|
|
|
Edizione |
[1st ed.] |
|
|
|
|
|
Descrizione fisica |
|
1 online resource (57 p.) |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Smallpox - Vaccination |
Smallpox vaccine |
Biological warfare |
Emergency medical services - United States |
Medical policy - United States |
Public health - United States |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
This report summarizes the discussions of [a] meeting, held on June 15, 2002 in Washington, D.C. |
|
|
|
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references. |
|
|
|
|
|
|
Nota di contenuto |
|
""SCIENTIFIC AND POLICY CONSIDERATIONS IN DEVELOPING SMALLPOX VACCINATION OPTIONS""; ""Copyright""; ""INDEPENDENT REPORT REVIEWERS""; ""Contents""; ""INTRODUCTION""; ""OPENING REMARKS""; ""SCIENTIFIC BACKGROUND ON SMALLPOX AND SMALLPOX VACCINATION""; ""SMALLPOX DISEASE""; ""SMALLPOX CONTROL STRATEGIES AND VACCINE AVAILABILITY""; ""SMALLPOX VACCINATION: EFFICACY, AVAILABILITY, DURATION OF IMMUNITY, AND TIMING""; ""SMALLPOX VACCINATION SAFETY""; ""CDC-ACIP SMALLPOX VACCINATION POLICY REVIEW""; ""CDC�S DRAFT POLICY OPTIONS""; ""SUMMARY OF REGIONAL MEETINGS"" |
""THE MODELING BASIS FOR VACCINATION POLICY OPTIONS""""MODEL 1""; ""MODEL 2""; ""MODEL 3""; ""SOVIET OUTBREAK OF SMALLPOX""; ""LESSONS LEARNED FROM RAPID MOBILIZATION FOR ANTHRAX MASS |
|
|
|
|
|
|
|
|
|
|
PROPHYLAXIS: IMPLICATIONS FOR SMALLPOX""; ""DISTRICT OF COLUMBIA""; ""ARLINGTON COUNTY, VIRGINIA""; ""MARYLAND""; ""EMERGENCY RESPONDERS""; ""EMERGENCY MEDICAL TECHNICIANS""; ""FIRE CHIEFS""; ""EMERGENCY SERVICES""; ""HEALTH CARE PROVIDERS""; ""NURSES""; ""EMERGENCY ROOM PHYSICIANS""; ""FAMILY PHYSICIANS""; ""PEDIATRICIANS""; ""HOSPITAL WORKERS""; ""HOSPITAL SYSTEMS""; ""SPECIAL POPULATIONS"" |
""ETHICAL, LEGAL, AND SOCIAL ISSUES""""ETHICAL CONSIDERATIONS""; ""INDEMNIFICATION FOR ADVERSE EVENTS""; ""COMMUNICATION""; ""RISK COMMUNICATION""; ""PUBLIC HEALTH RISKS AND BENEFITS""; ""PERSPECTIVE 1""; ""PERSPECTIVE 2""; ""PERSPECTIVE 3""; ""PERSPECTIVE 4""; ""PUBLIC COMMENTS AND DISCUSSION""; ""USE OF SCARCE PUBLIC HEALTH RESOURCES AND INSURING DUAL USE APPROACHES""; ""VACCINE DEVELOPMENT AND APPROVAL""; ""INTERNATIONAL CONSIDERATIONS""; ""UNCERTAINTIES""; ""COMMUNICATION AND EDUCATION""; ""EPILOGUE"" |
""DRAFT SUPPLEMENTAL RECOMMENDATIONS OF THE ACIP USE OF SMALLPOX (VACCINIA) VACCINE, JUNE 2002""""PRE-RELEASE VACCINATION OF THE GENERAL POPULATION""; ""PRE-RELEASE VACCINATION OF SELECTED GROUPS TO ENHANCE SMALLPOX RESPONSE READINESS""; ""Smallpox Response Teams""; ""Designated Smallpox Healthcare Personnel at Designated Hospitals""; ""Implementation of Recommendations"" |
|
|
|
|
|
| |